Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 18 studies | 57% ± 21% | |
peripheral blood | 11 studies | 22% ± 4% | |
lung | 11 studies | 29% ± 12% | |
eye | 9 studies | 38% ± 15% | |
heart | 5 studies | 36% ± 12% | |
kidney | 5 studies | 29% ± 11% | |
liver | 5 studies | 30% ± 18% | |
adipose | 4 studies | 44% ± 23% | |
intestine | 3 studies | 21% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1755.81 | 1444 / 1445 | 100% | 29.43 | 183 / 183 |
brain | 100% | 5009.65 | 2641 / 2642 | 100% | 62.09 | 704 / 705 |
ovary | 100% | 1912.44 | 180 / 180 | 100% | 23.18 | 429 / 430 |
breast | 100% | 2191.61 | 459 / 459 | 100% | 43.79 | 1114 / 1118 |
lung | 99% | 2026.72 | 574 / 578 | 100% | 27.87 | 1153 / 1155 |
skin | 100% | 3136.49 | 1809 / 1809 | 97% | 40.09 | 460 / 472 |
prostate | 100% | 1949.96 | 244 / 245 | 98% | 26.50 | 491 / 502 |
bladder | 100% | 1995.48 | 21 / 21 | 97% | 20.88 | 490 / 504 |
stomach | 100% | 1467.20 | 359 / 359 | 97% | 17.92 | 278 / 286 |
intestine | 100% | 1942.98 | 966 / 966 | 97% | 17.80 | 511 / 527 |
uterus | 100% | 2138.59 | 170 / 170 | 97% | 22.06 | 444 / 459 |
thymus | 100% | 1566.35 | 651 / 653 | 97% | 19.74 | 587 / 605 |
adrenal gland | 100% | 1868.94 | 258 / 258 | 94% | 21.46 | 217 / 230 |
kidney | 100% | 1214.20 | 89 / 89 | 93% | 16.46 | 842 / 901 |
pancreas | 95% | 898.02 | 311 / 328 | 98% | 18.46 | 174 / 178 |
liver | 92% | 821.31 | 208 / 226 | 72% | 9.74 | 293 / 406 |
adipose | 100% | 2064.68 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 2000.94 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.82 | 1 / 1 |
blood vessel | 100% | 1891.92 | 1332 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 2583.42 | 902 / 929 | 0% | 0 | 0 / 0 |
muscle | 96% | 1069.65 | 773 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 21.65 | 42 / 45 |
heart | 90% | 1117.49 | 775 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 90% | 22.77 | 72 / 80 |
lymph node | 0% | 0 | 0 / 0 | 90% | 16.25 | 26 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0018105 | Biological process | peptidyl-serine phosphorylation |
GO_0001525 | Biological process | angiogenesis |
GO_0045071 | Biological process | negative regulation of viral genome replication |
GO_0045087 | Biological process | innate immune response |
GO_0050684 | Biological process | regulation of mRNA processing |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0035063 | Biological process | nuclear speck organization |
GO_0043525 | Biological process | positive regulation of neuron apoptotic process |
GO_0045070 | Biological process | positive regulation of viral genome replication |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0008380 | Biological process | RNA splicing |
GO_0048024 | Biological process | regulation of mRNA splicing, via spliceosome |
GO_0062176 | Biological process | R-loop processing |
GO_0030154 | Biological process | cell differentiation |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0006468 | Biological process | protein phosphorylation |
GO_0000245 | Biological process | spliceosomal complex assembly |
GO_0045787 | Biological process | positive regulation of cell cycle |
GO_0005730 | Cellular component | nucleolus |
GO_0016607 | Cellular component | nuclear speck |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0071889 | Molecular function | 14-3-3 protein binding |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0000287 | Molecular function | magnesium ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | SRPK2 |
Protein name | SRSF protein kinase 2 non-specific serine/threonine protein kinase (EC 2.7.11.1) Uncharacterized protein SRPK2 SRSF protein kinase 2 (EC 2.7.11.1) (SFRS protein kinase 2) (Serine/arginine-rich protein-specific kinase 2) (SR-protein-specific kinase 2) [Cleaved into: SRSF protein kinase 2 N-terminal; SRSF protein kinase 2 C-terminal] |
Synonyms | |
Description | FUNCTION: Serine/arginine-rich protein-specific kinase which specifically phosphorylates its substrates at serine residues located in regions rich in arginine/serine dipeptides, known as RS domains and is involved in the phosphorylation of SR splicing factors and the regulation of splicing . Promotes neuronal apoptosis by up-regulating cyclin-D1 (CCND1) expression . This is done by the phosphorylation of SRSF2, leading to the suppression of p53/TP53 phosphorylation thereby relieving the repressive effect of p53/TP53 on cyclin-D1 (CCND1) expression . Phosphorylates ACIN1, and redistributes it from the nuclear speckles to the nucleoplasm, resulting in cyclin A1 but not cyclin A2 up-regulation . Plays an essential role in spliceosomal B complex formation via the phosphorylation of DDX23/PRP28 . Probably by phosphorylating DDX23, leads to the suppression of incorrect R-loops formed during transcription; R-loops are composed of a DNA:RNA hybrid and the associated non-template single-stranded DNA . Can mediate hepatitis B virus (HBV) core protein phosphorylation . Plays a negative role in the regulation of HBV replication through a mechanism not involving the phosphorylation of the core protein but by reducing the packaging efficiency of the pregenomic RNA (pgRNA) without affecting the formation of the viral core particles . . |
Accessions | ENST00000474770.1 ENST00000465072.5 C9JWF7 ENST00000482862.2 F8WBW4 ENST00000357311.7 [P78362-1] ENST00000393651.8 [P78362-2] ENST00000482897.6 ENST00000460391.6 ENST00000477925.6 C9J2M4 H7C5L6 Q75MW9 ENST00000465112.5 A0A994J591 H7C521 ENST00000489828.5 [P78362-1] P78362 F8WAV6 |